Skip to main content
Commercial Medical Policy Notification Effective September 10, 2025 Posted July 16, 2025
Medical PolicyRevision
Quantitative ElectroencephalographyUpdated description, policy guidelines, and references added. Updated When Not Covered with the following: “Quantitative electroencephalographic (EEG)-based assessment of the theta:beta ratio is considered investigational as a diagnostic aid for for cognitive impairment and all mental health diagnosis, including but not limited to: Major depressive disorder; Substance use disorder diagnoses; Post-traumatic stress disorder; Conversion disorder with seizures or convulsions; Anxiety disorder/generalized anxiety disorder; Postconcussional syndrome; Autism spectrum disorders. Specialty Matched Consultant Advisory Panel review 6/2025. Medical Director review 6/2025. Notification given 7/16/2025 for effective date 9/10/2025.